296 related articles for article (PubMed ID: 21356477)
1. The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy.
Wahl RL; Herman JM; Ford E
Semin Radiat Oncol; 2011 Apr; 21(2):88-100. PubMed ID: 21356477
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
3. Automated functional image-guided radiation treatment planning for rectal cancer.
Ciernik IF; Huser M; Burger C; Davis JB; Szekely G
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):893-900. PubMed ID: 15936575
[TBL] [Abstract][Full Text] [Related]
4. Defining radiotherapy target volumes using 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography: still a Pandora's box?
Devic S; Tomic N; Faria S; Menard S; Lisbona R; Lehnert S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1555-62. PubMed ID: 20646840
[TBL] [Abstract][Full Text] [Related]
5. A realistic utilization of nanotechnology in molecular imaging and targeted radiotherapy of solid tumors.
Patel V; Papineni RV; Gupta S; Stoyanova R; Ahmed MM
Radiat Res; 2012 Apr; 177(4):483-95. PubMed ID: 22404738
[TBL] [Abstract][Full Text] [Related]
6. The Current Role of PET/CT in Radiotherapy Planning.
Lee ST; Scott AM
Curr Radiopharm; 2015; 8(1):38-44. PubMed ID: 25808960
[TBL] [Abstract][Full Text] [Related]
7. Clinical applications of positron emission tomography/computed tomography treatment planning.
Macapinlac HA
Semin Nucl Med; 2008 Mar; 38(2):137-40. PubMed ID: 18243849
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of breast cancer.
Oude Munnink TH; Nagengast WB; Brouwers AH; Schröder CP; Hospers GA; Lub-de Hooge MN; van der Wall E; van Diest PJ; de Vries EG
Breast; 2009 Oct; 18 Suppl 3():S66-73. PubMed ID: 19914546
[TBL] [Abstract][Full Text] [Related]
9. PET and SPECT for radiation treatment planning.
Götz L; Spehl TS; Weber WA; Grosu AL
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):163-72. PubMed ID: 22617238
[TBL] [Abstract][Full Text] [Related]
10. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X
Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896
[TBL] [Abstract][Full Text] [Related]
11. PET/CT in External Beam Radiation Therapy Dose Planning.
Kairemo K
Curr Radiopharm; 2015; 8(1):1. PubMed ID: 25808956
[No Abstract] [Full Text] [Related]
12. Imaging of Integrin α
Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions.
Das SK; Miften MM; Zhou S; Bell M; Munley MT; Whiddon CS; Craciunescu O; Baydush AH; Wong T; Rosenman JG; Dewhirst MW; Marks LB
Med Phys; 2004 Jun; 31(6):1452-61. PubMed ID: 15259648
[TBL] [Abstract][Full Text] [Related]
14. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments.
Price PM; Green MM
Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S19-34. PubMed ID: 21427180
[TBL] [Abstract][Full Text] [Related]
16. PET radiopharmaceuticals in radiation treatment planning - synthesis and biological characteristics.
Haubner R
Radiother Oncol; 2010 Sep; 96(3):280-7. PubMed ID: 20724013
[TBL] [Abstract][Full Text] [Related]
17. [The contribution of PET to radiation treatment planning].
Belkacémi Y; Lartigau E; Kerrou K; Carpentier P; Taïeb S; Giraud P
Bull Cancer; 2007 Jan; 94(1):99-108. PubMed ID: 17237010
[TBL] [Abstract][Full Text] [Related]
18. A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.
Tachibana I; Nishimura Y; Shibata T; Kanamori S; Nakamatsu K; Koike R; Nishikawa T; Ishikawa K; Tamura M; Hosono M
J Radiat Res; 2013 Nov; 54(6):1078-84. PubMed ID: 23589026
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
[TBL] [Abstract][Full Text] [Related]
20. Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer.
Moule RN; Kayani I; Prior T; Lemon C; Goodchild K; Sanghera B; Wong WL; Saunders MI
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):364-71. PubMed ID: 21109410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
